Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Study of Personalized Therapy for Non-small Cell Lung Cancer Based on ERCC1/RRM1/TS Expression

NCT01781988 is registered in ClinicalTrials.gov with Guangzhou Medical University as lead sponsor.

NCT NCT01781988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Study of Personalized Therapy for Non-small Cell Lung Cancer Based on ERCC1/RRM1/TS Expression
Lead sponsor
Guangzhou Medical University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2014
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carboplatin adverse reaction, lung cancer